Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Half Year ended September 30, 2026 (Q2 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 30 and 33 of SEBI LODR Regulations

Audit Opinion:

Clean opinion (unmodified report) from statutory auditors Walker Chandiok & Co LLP for both standalone and consolidated financial results.

Auditor’s Comment:

Auditors drew attention to Note 4 (standalone) and Note 6 (consolidated) regarding tax demands raised by Income-tax authorities. For standalone: ₹600.92 million demand for block period April 1, 2018 to March 12, 2025. For consolidated: ₹1,560.18 million demand for same period. Company has filed appeals and management believes no adjustments are required in the financial statements. Auditors' conclusion is not modified regarding this matter.

Key Financial Highlights [₹ in million]:

Standalone Results:

Quarter ended September 30, 2026:

  • Revenue from Operations: ₹3,922.75 (Q2 FY26: ₹3,093.15 | YoY: +26.8%)
  • Total Income: ₹4,183.79 (Q2 FY26: ₹3,363.92 | YoY: +24.4%)
  • Net Profit: ₹326.37 (Q2 FY26: ₹234.62 | YoY: +39.1%)
  • EPS: ₹2.13 (Q2 FY26: ₹1.53 | YoY: +39.2%)

Half Year ended September 30, 2026:

  • Revenue from Operations: ₹7,873.22 (H1 FY26: ₹6,417.58 | YoY: +22.7%)
  • Total Income: ₹8,392.23 (H1 FY26: ₹6,973.90 | YoY: +20.3%)
  • Net Profit: ₹683.29 (H1 FY26: ₹448.39 | YoY: +52.4%)
  • EPS: ₹4.46 (H1 FY26: ₹2.93 | YoY: +52.2%)

Balance Sheet (Standalone as at September 30, 2026):

  • Paid-up share capital: ₹306.21 million
  • Other equity: ₹24,282.12 million
  • Cash and cash equivalents: ₹396.27 million
  • Total assets: ₹29,057.92 million

Consolidated Results:

Quarter ended September 30, 2026:

  • Revenue from Operations: ₹13,423.87 (Q2 FY26: ₹10,175.30 | YoY: +31.9%)
  • Total Income: ₹13,712.93 (Q2 FY26: ₹10,498.95 | YoY: +30.6%)
  • Net Profit: ₹1,145.65 (Q2 FY26: ₹426.96 | YoY: +168.3%)
  • EPS: ₹7.37 (Q2 FY26: ₹2.66 | YoY: +177.1%)
  • Profit attributable to owners: ₹1,128.51 million

Half Year ended September 30, 2026:

  • Revenue from Operations: ₹25,090.16 (H1 FY26: ₹20,415.62 | YoY: +22.9%)
  • Total Income: ₹25,683.02 (H1 FY26: ₹21,006.58 | YoY: +22.3%)
  • Net Profit: ₹2,155.43 (H1 FY26: ₹1,073.81 | YoY: +100.7%)
  • EPS: ₹13.90 (H1 FY26: ₹6.81 | YoY: +104.1%)
  • Profit attributable to owners: ₹2,128.61 million

Balance Sheet (Consolidated as at September 30, 2026):

  • Paid-up share capital: ₹306.21 million
  • Other equity: ₹34,722.46 million
  • Cash and cash equivalents: ₹1,835.93 million
  • Total assets: ₹58,315.71 million

Segment-wise Performance [₹ in million]:

The Group operates in five business segments:

Quarter ended September 30, 2026 (External Revenue):

  • CDMO: ₹11,148.66 (83.0% of total)
  • API: ₹287.71 (2.1% of total)
  • Domestic Branded Formulations: ₹1,319.20 (9.8% of total)
  • International Branded Formulations: ₹437.79 (3.3% of total)
  • Trade Generics: ₹230.51 (1.7% of total)

Segment Results before depreciation (Q2 FY26):

  • CDMO: ₹1,682.43 (Q2 FY26: ₹843.10 | YoY: +99.6%)
  • API: (₹57.41) (Q2 FY26: (₹140.31))
  • Domestic Branded Formulations: ₹240.37 (Q2 FY26: ₹263.87 | YoY: -8.9%)
  • International Branded Formulations: ₹99.07 (Q2 FY26: ₹54.88 | YoY: +80.5%)
  • Trade Generics: ₹11.85 (Q2 FY26: (₹28.73))

Corporate Actions:

  • Dividend: Shareholders at AGM held on July 10, 2026 approved final dividend of ₹1 per equity share and special dividend of ₹2 per equity share (aggregate ₹3 per equity share) for FY26.
  • Total dividend liability: ₹472.18 million
  • Amount paid during Q2 FY27: ₹472.12 million (including ₹12.88 million to ESOP Trust)
  • Unclaimed dividend: ₹0.06 million

Other Significant Information:

  • Pure and Cure Healthcare Private Limited (wholly-owned subsidiary) completed acquisition of manufacturing business of OriOame India Private Limited for ₹560.00 million during the quarter.
  • Acquisition includes manufacturing facilities at Roorkee and Noida with leased warehouse.
  • ESOP Trust treated as extension of Company, shares held by trust netted off from paid-up capital.
  • Company deposited ₹9 million (standalone) and ₹70.54 million (consolidated) as advance under protest against tax demand during the quarter.
  • Subsequent to quarter end, further deposits of ₹16.20 million (standalone) and ₹39.20 million (consolidated) made under protest.